Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
This report contains market size and forecasts of Irritable Bowel Syndrome (IBS) Diagnostics in Global, including the following market information:
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Irritable Bowel Syndrome (IBS) Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laboratory Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome (IBS) Diagnostics include Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc. and Sysmex Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Irritable Bowel Syndrome (IBS) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, by Type, 2021 (%)
Laboratory Tests
Imaging Tests
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Diagnostic Centers
Others
Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome (IBS) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome (IBS) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Commonwealth Diagnostics International
Genova Diagnostics
Gemelli Biotech
Prometheus Laboratories
Inova Diagnostics, Inc.
Biohit Oyj
Aerodiagnostics, LLC.
Metabolic Solutions, Inc.
Sysmex Corporation
Buhlmann Laboratories AG